{
 "id": "xpertsystems/hconc005-sample",
 "owner": "xpertsystems",
 "name": "hconc005-sample",
 "downloads": 24,
 "likes": 0,
 "last_modified": "2026-05-26T21:22:49.000Z",
 "stated_licence": "cc-by-nc-4.0",
 "stated_from": "tag",
 "licence_name": null,
 "licence_link": null,
 "file_licence": null,
 "licence_files": [],
 "sources": [],
 "gated": false,
 "tasks": [
  "tabular-classification",
  "tabular-regression",
  "time-series-forecasting",
  "survival-analysis"
 ],
 "citation": "@dataset{xpertsystems_hconc005_2026,\n  title  = {HC-ONC-005: Pancreatic Cancer (PDAC) Synthetic Cohort with CA 19-9 Longitudinal Panel and Five Relational Tables},\n  author = {{XpertSystems.ai}},\n  year   = {2026},\n  version= {1.0.0},\n  url    = {https://huggingface.co/datasets/xpertsystems/hconc005-sample},\n  license= {CC-BY-NC-4.0 (sample); Commercial (full product)},\n  note   = {Calibrated against SEER PDAC 2017-2021, TCGA PAAD molecular frequencies (Waddell 2015, Bailey 2016), NCCN Pancreatic Adenocarcinoma Guidelines 2024, AJCC 8th Edition, ISGPF 2016 fistula grading, ISGPS DGE grading, PRODIGE-4 / ACCORD-11 (Conroy 2011 FOLFIRINOX), MPACT (Von Hoff 2013 Gem+NabP), POLO (Golan 2019 olaparib maintenance), NAPOLI-3 (Wainberg 2023 NALIRIFOX), KEYNOTE-158 (Marabelle 2020 pembrolizumab MSI-H), KRYSTAL-1 (Skoulidis 2021 sotorasib G12C), Pritchard 2016 (BRCA2 prevalence), Iacobuzio-Donahue 2009 (SMAD4), Yachida 2010 (metastasis patterns), Hidalgo 2010 (head tumor proportion), Cohen 2018 (PDAC ctDNA).}\n}",
 "signal": "restrictive",
 "reason": "The declared licence (cc-by-nc-4.0) is classified as having use restrictions.",
 "revision": "10573cea06438f3d720e03f57542876ae9890c94",
 "stated_evidence": "https://huggingface.co/datasets/xpertsystems/hconc005-sample/blob/10573cea06438f3d720e03f57542876ae9890c94/README.md",
 "file_evidence": "https://huggingface.co/datasets/xpertsystems/hconc005-sample/tree/10573cea06438f3d720e03f57542876ae9890c94",
 "card_nc": false
}